Filing Details

Accession Number:
0001181431-14-022758
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-05 07:48:30
Reporting Period:
2014-06-04
Filing Date:
2014-06-05
Accepted Time:
2014-06-05 07:48:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533040 Rxi Pharmaceuticals Corp RXII Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1285648 Geert Cauwenbergh C/O Rxi Pharmaceuticals Corporation
257 Simarano Drive, Suite 101
Marlborough MA 01752
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Acquisiton 2014-06-04 1,000 $2.91 22,100 No 4 P Direct
Common Stock, $0.0001 Par Value Acquisiton 2014-06-04 1,000 $2.97 23,100 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct